Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
Biotech Business August 2024
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
2024 Global Forecast for Synthetic Biology Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx ... Read More
-
Global Pharmaceutical Quality Control Market Size Study, by Product (Consumables, Instruments, Services), by Analysis Type (Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing, Raw Material Testing, Others), by Products Tested (Vaccines, Plasma Products, Drugs) and Regional Forecasts 2022-2032
... Plasma Products, Drugs) and Regional Forecasts 2022-2032 Global Pharmaceutical Quality Control Market is valued at approximately USD 4.71 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.21% ... Read More
-
2024 Global Forecast for Biotechnology (2025-2030 Outlook)-High Tech & Emerging Markets Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2025 to ... Read More
-
eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, Safety), Deployment (On premise, Cloud), Application (Collection, Operations, Analytics), Trial Phase, End user (Pharma, Biotech, Med Devices), & Region - Global Forecast to 2029
... global eClinical solutions market is projected to reach USD 22.1 billion by 2029 from USD 11.6 billion in 2024, at a high CAGR of 13.7% during the forecast period. Growth Drivers include the rising operational ... Read More
-
Engineered Antibody Therapeutics for Cancer
... driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and VHH. ... Read More
-
Global Organs on Chips Market 2024-2028
... forecast period. The report on the organs on chips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Synthetic Biology Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Diverse Application of Synthetic Biology will trigger the market growth ... Read More
-
Global Analytical Standards Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Guangzhou Wondfo Biotech Co Ltd (300482) - Product Pipeline Analysis, 2024 Update
... kits. It also offers fertility and thyroid testing devices, immunofluorescence reagents, molecular diagnostic equipment, blood gas, coagulation analyzers and dry chemistry analyzers. The company's products are widely used in the rapid diagnosis and effective treatment ... Read More
-
Biotech Research and Development - 2024 U.S. Market Research Report with Updated Recession Risk Forecasts
... in-depth assessments of the industry in the United States with over 100+ data sets covering 2015-2028. This Kentley Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns ... Read More
-
Engineering and Life Sciences Research and Development - 2024 U.S. Market Research Report with Updated Recession Risk Forecasts
... and in-depth assessments of the industry in the United States with over 100+ data sets covering 2015-2028. This Kentley Insights report is full of industry insights including historical and forecasted market size, revenue and industry ... Read More
-
Genome-Based Drug Companies in China
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Biotechnology Markets in China
... high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, ... Read More
-
Biotechnology Industry Forecasts - China Focus
... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the ... Read More
-
Global DNA and Gene Chip Market Analysis & Trends - Industry Forecast to 2030
... reach $24.8 billion by 2030. Based on our analysis the market is expected to grow at a CAGR of 15.6% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing ... Read More
-
Biophotonics
... of 10.8% over the analysis period 2023-2030. See-through Imaging Application, one of the segments analyzed in the report, is expected to record a 0.1% CAGR and reach US$34.1 Billion by the end of the analysis ... Read More
-
RNA Interference (RNAi)
... by 2030, growing at a CAGR of 11.0% over the analysis period 2023-2030. Drug Discovery & Development Application, one of the segments analyzed in the report, is expected to record a 16.4% CAGR and reach ... Read More
-
Biobank Management Systems Market By Sample Type (Absorbable Human Tissue & Organ Samples, Plant & Animal Samples, Microbial Samples) , By Application (Regenerative Medicine, Life Science Research, Clinical Research, Environmental Research) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... and Industry Forecast, 2024-2033 The biobank management systems market was valued at $2.1 billion in 2023, and is projected to reach $4.6 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033. ... Read More
-
Biobanks
... of 8.0% over the analysis period 2023-2030. Physical / Real Biobanks, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$99.2 Billion by the end of the ... Read More
-
Human Embryonic Stem Cell (hESC) Research
... the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Regenerative Medicine Application, one of the segments analyzed in the report, is expected ... Read More
-
Drug Discovery Technologies
... by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. Small Molecule Drugs Discovery Technologies, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach ... Read More
-
Biotech Business July 2024
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Synthetic Biology
... at a CAGR of 28.0% over the analysis period 2023-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is expected to record a 29.3% CAGR and reach US$39.5 Billion by the ... Read More
-
Cancer Therapies
... at a CAGR of 10.4% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$112.8 Billion by the end of the ... Read More
Research Assistance
